Damora Therapeutics, Inc. (DMRA)

Damora Therapeutics Statistics

Total Valuation

DMRA has a market cap or net worth of $1.54 billion. The enterprise value is $1.28 billion.

Market Cap	1.54B
Enterprise Value	1.28B

Important Dates

The next estimated earnings date is Thursday, April 30, 2026, after market close.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

DMRA has 60.30 million shares outstanding. The number of shares has increased by 17.79% in one year.

Current Share Class	60.30M
Shares Outstanding	60.30M
Shares Change (YoY)	+17.79%
Shares Change (QoQ)	+11.55%
Owned by Insiders (%)	0.24%
Owned by Institutions (%)	2.05%
Float	47.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.40
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.98, with a Debt / Equity ratio of 0.00.

Current Ratio	12.98
Quick Ratio	12.88
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -163.80% and return on invested capital (ROIC) is -17.83%.

Return on Equity (ROE)	-163.80%
Return on Assets (ROA)	-16.46%
Return on Invested Capital (ROIC)	-17.83%
Return on Capital Employed (ROCE)	-15.20%
Weighted Average Cost of Capital (WACC)	12.89%
Revenue Per Employee	n/a
Profits Per Employee	-$29.98M
Employee Count	7
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DMRA has paid $50,000 in taxes.

Income Tax	50,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +547.21% in the last 52 weeks. The beta is 1.57, so DMRA's price volatility has been higher than the market average.

Beta (5Y)	1.57
52-Week Price Change	+547.21%
50-Day Moving Average	26.42
200-Day Moving Average	14.45
Relative Strength Index (RSI)	50.39
Average Volume (20 Days)	291,097

Short Selling Information

The latest short interest is 427,713, so 0.71% of the outstanding shares have been sold short.

Short Interest	427,713
Short Previous Month	325,076
Short % of Shares Out	0.71%
Short % of Float	0.90%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-36.56M
Pretax Income	-209.79M
Net Income	-209.84M
EBITDA	-36.54M
EBIT	-36.56M
Earnings Per Share (EPS)	-$153.95

Balance Sheet

The company has $257.62 million in cash and $68,000 in debt, with a net cash position of $257.56 million or $4.27 per share.

Cash & Cash Equivalents	257.62M
Total Debt	68,000
Net Cash	257.56M
Net Cash Per Share	$4.27
Equity (Book Value)	240.38M
Book Value Per Share	-110.10
Working Capital	240.36M

Cash Flow

Operating Cash Flow	-6.73M
Capital Expenditures	n/a
Depreciation & Amortization	22,000
Net Borrowing	n/a
Free Cash Flow	-6.73M
FCF Per Share	-$0.11

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DMRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.79%
Shareholder Yield	-17.79%
Earnings Yield	-13.65%
FCF Yield	-0.44%

Analyst Forecast

The average price target for DMRA is $46.00, which is 80.39% higher than the current price. The consensus rating is "Buy".

Price Target	$46.00
Price Target Difference	80.39%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 30, 2024. It was a reverse split with a ratio of 1:25.

Last Split Date	Aug 30, 2024
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	1